is-elestrin-right-for-you
 
 

The amount of Elestrin your doctor prescribes for you is flexible and can help you avoid the need for a new prescription if your dose is adjusted.

Your doctor will start you off using the one-pump or the two-pump dose. Your doctor may then adjust your dose, depending on your progress. Each prescription will provide 50-100 doses of Elestrin, depending on whether your doctor prescribes 1- or 2-pump dose for you. At the 1-pump dose, you may need as few as 4 co-payments per year. At the 2-pump dose, you may have up to 8.

Of course, only your doctor can determine the dose of Elestrin that is right for you.

Regardless of which dose your doctor starts you on, if your doctor adjusts your dose, you simply increase or decrease the number of pumps you use with each application, rather than going to buy a new prescription.

 

Important Safety InformationElestrin is indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.

Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia. Estrogen and progestin therapy has shown an increased risk of breast cancer, heart attack, and blood clots. Estrogen therapy, with or without progestins, increases the risk of stroke and dementia. Estrogen therapy alone increases the risk of endometrial cancer. The most frequently reported adverse events in clinical trials were nasopharyngitis, breast tenderness, upper respiratory tract infection, and metrorrhagia.

Please see Full Prescribing Information, including Black Box Warning

 
 

Close (x)

A Survey of 300 untreated menopausal women reveal what they want from the application of transdermal estrogen therapy†:

"I want a product I can apply and forget it."

"I’d rather just rub the product in and forget it’s there."

"For me, it’s easier to get into a daily habit."

"I like the control of applying [it] right on my upper arm."

"Make it clear and easy to apply."

†A blinded survey of 300 women with hot flashes to evaluate the importance of various attributes of transdermal estrogen therapy and the preference for various topical estrogen therapy products. Azur Pharma; 2009.